Australia’s dedicated
online psoriasis clinic
Specialist appointments within 2 weeks
See a dermatologist via video consultation without the wait.
No referral needed
You can see a dermatologist directly—just note that without a GP referral, Medicare rebates won’t apply. Find out more.
Nurse concierge service
Our expert nurses are here for you – available 9am to 9pm, Monday to Friday, to answer your queries and offer support.
Medications delivered to your door
In partnership with ACE Pharmacy. Includes cold-chain logistics for biologics. Read more.
Start your personalised treatment today.
How it works
1. Book your appointment
See a specialist within 2 weeks. Convenient online payment. Receive your secure video link.
2. Consult with your dermatologist
Connect with a dermatologist via video and get eScripts sent to your phone.
3. Home delivery
Get your medications delivered to your door – completely free.
4. Nurse support
Need help or guidance with your treatment? Our nurses are here for you.
Why focus on psoriasis
Psoriasis is complex and often overlooked. At Digital Dermatology, we specialise in treating it.
Our experience means faster access to expert advice, personalised care, and support from doctors who understand the daily impact of this condition.
New treatment options are available
Clearer skin may be possible with dermatologist-led care, including PBS-listed therapies.
Australia's leading dermatologists
Dermatologists are Fellows of the Australasian College of Dermatologists (FACD), the peak professional body for skin specialists.
Meet Australia's Psoriasis expert
A/Prof Peter Foley
A/Prof Foley is the Director of Research at the Skin Health Institute and the Head of Dermatology Research at St Vincent’s Hospital Melbourne.
He has been a councillor on the International Psoriasis Council (IPC) since 2012, is a founding member of the Australasian Psoriasis Collaboration, and is a former steering committee member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), now a member of GRAPPA Treatment Recommendations – Psoriasis Workgroup.
What new treatments are available for psoriasis?
Australians with moderate-to-severe plaque psoriasis now have access to advanced therapies through the Pharmaceutical Benefits Scheme (PBS). These include biologic medicines and oral treatments like deucravacitinib (Sotyktu) and apremilast (Otezla). These options have significantly improved outcomes for many patients.
What are biologics?
Biologics are a class of advanced medications used to treat moderate-to-severe psoriasis. They work by targeting specific parts of the immune system that drive inflammation and skin cell overgrowth. Unlike traditional treatments, biologics are more selective, meaning they often offer better results with fewer side effects for eligible patients.
These treatments are typically given by injection and can lead to significant or near-complete skin clearance in many people.
Current biologics for psoriasis include adalimumab, adalimumab, bimekizumab, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, secukinumab, tildrakizumab, ustekinumab.
Who can access biologics in Australia?
In Australia, biologics are available through the Pharmaceutical Benefits Scheme (PBS) for people with:
- A Psoriasis Area and Severity Index (PASI) score greater than 15, or significant involvement of sensitive areas such as the face, palms, or soles.
- Failure to achieve adequate response to at least two of the following treatments: phototherapy, methotrexate, cyclosporine, acitretin, deucravacitinib or apremilast.
Access usually requires assessment and prescription by a dermatologist.
Your dermatologist will help select the right option based on your health history, psoriasis type, and response to past treatments.
What is deucravacitinib (Sotyktu), and who can prescribe it?
Deucravacitinib is an oral medication approved for adults with moderate-to-severe plaque psoriasis. It works by selectively inhibiting the TYK2 enzyme, reducing inflammation. Under the PBS, initiation of deucravacitinib treatment must be done by a dermatologist. Subsequent prescriptions can be provided by a GP.
What about apremilast (Otezla)?
Apremilast is another oral treatment option for adults with moderate-to-severe plaque psoriasis. It inhibits the phosphodiesterase 4 (PDE4) enzyme, helping to control inflammation. Apremilast is listed on the PBS, making it more accessible to eligible patients.
Do I need a referral to see a dermatologist?
While you can consult a dermatologist without a referral, please note that without a GP referral, you won’t be eligible for a Medicare rebate for the consultation fee.
However, you can still access PBS-subsidised medications if prescribed by a dermatologist.
Is there a cure for psoriasis?
Currently, there is no cure for psoriasis. However, with the latest treatments, many patients achieve significant improvement or clear skin. Ongoing management with a dermatologist can help maintain these results.